✦ LIBER ✦

Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study

✍ Scribed by Fariba Mozaffari; Christina Lindemalm; Aniruddha Choudhury; Helena Granstam-Björneklett; Mats Lekander; Bo Nilsson; Marja-Leena Ojutkangas; Anders Österborg; Leif Bergkvist; Håkan Mellstedt

Book ID: 105967451
Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 516 KB
Volume: 58
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-008-0530-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of adjuvant chemotherapy w

Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer

✍ Stephen E. Jones; Robert G. Mennel; George N. Peters; Mary Alice Westrick; Barry 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 263 KB

Epirubicin is a new anthracycline with a potentially more favorable toxicity profile than the parent compound, doxorubicin. Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients w

Risk of venous thromboembolism in patien

Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer

✍ Julia HOY; Teresa NEEMAN; Robin STUART-HARRIS; Alison DAVIS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Adjuvant Therapy of Breast Cancer with P

Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil

✍ Jun-Jie Li; Gen-Hong Di; Li-Chen Tang; Ke-Da Yu; Zhen Hu; Guang-Yu Liu; Jing-Son 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Prospective randomized study of cyclopho

Prospective randomized study of cyclophosphamide, epirubicin, and 5-fluorouracil versus cyclophosphamide, adriamycin, and 5-fluorouracil in advanced or recurrent breast cancer

✍ Tetsuro Kobayashi; Hiroki Koyama; Takahiro Oka; Tadaki Yasumura; Norimichi Kan; 📂 Article 📅 1999 🏛 Springer Japan 🌐 English ⚖ 475 KB

Randomized trial of cyclophosphamide, ep

Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan

✍ Morihiko Kimura; Takeshi Tominaga; Yuichi Takatsuka; Masakazu Toi; Rikiya Abe; H 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 224 KB

On the safety of perioperative adjuvant

On the safety of perioperative adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil in breast cancer

📂 Article 📅 1988 🏛 Elsevier Science ⚖ 409 KB